SGX Listed Stock

SINGAPORE EDEVELOPMENT LTD (SGX:40V)


SGD 0.062
-0.012 / -16.22%
Share Price as of: 2020-08-14 17:16
Market / ISIN Code: Catalist / SG1AE2000006
GICS® Sector / Industry Group / Industry: Real Estate / Real Estate / Real Estate Management and Development


Singapore E-Development Blogger ArticlesSINGAPORE EDEVELOPMENT LTD Blogger Articles SGX Listed SINGAPORE EDEVELOPMENT LTD (SGX:40V) Blogger Articles 40V.SI Blogger Articles
A Path to Forever Financial Freedom (3Fs)
B
2020-06-25 00:27:40
A Speculative Story of Three Potential "Multi-Bagger" Positions
In the past recent days, I've taken three small speculative positions and have kept them relatively small as an overall percentage of the portfolio.These are positions which I've taken without doing too much due diligence and reading too much of its fundamentals due to the nature of the companies (but yes I've weighed in the risk reward probability) and both have announced big news in the past week.WirecardI've written an article recently about the company (Link Here) after its scandal news were splattered all across the Internet.After 5 consecutive days of the stock dropping from $100 to $14, my itchy hands decided to buy in a little at 200 shares @ $16.7 and I added another 80 shares @ $13.2.My average price is now at around $15.8, and I am close to 20% down.My thesis for buying was
SIAS
sias
2020-04-26 21:16:15
Negative oil prices added to the uncertainty
Negative oil and Gilead disappointment drag 3.7% off STI; Some European countries start partial reopening; US jobless claims continued to rise; Singapore banks will start earnings reporting this week; SIA responded to SIAS Last week will probably be remembered for oil prices crashing into negative territory, a development which has shocked investors and brought the sellers out in global stocks. Also dampening sentiment was an announcement on Thursday by US drug company Gilead that it did not have conclusive evidence that its experimental drug was effective in treating Covid-19 since it had terminated a trial in China early. Markets had earlier in the month risen sharply on hopes that Gilead’s drug might lead to a vaccine. However, on the upside, providing support for equities was new





Investment BloggerSG Investment BlogSG Invest BloggersBloggers Say








Your Say











Stock / REIT Search

Advertisement

Advertisement